Patents by Inventor Limin Gong

Limin Gong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7588927
    Abstract: The invention relates to a novel protease, called SENP1, which is active against sentrin-modified proteins in vivo. The invention more specifically relates to the genomic and amino acid sequences for SENP1, compositions related to and based on these sequences, and methods of using these sequences and compositions.
    Type: Grant
    Filed: July 22, 2003
    Date of Patent: September 15, 2009
    Assignees: National Institutes of Health (NIH), The United States of America as represented by the Department of Health and Human Services, U.S. Government NIH Divisional of Extramural Inventions and Technology Resources (DEITR)
    Inventors: Edward T. H. Yeh, Limin Gong
  • Publication number: 20060134741
    Abstract: The invention relates to a novel protease, called SENP1, which is active against sentrin-modified proteins in vivo. The invention more specifically relates to the genomic and amino acid sequences for SENP1, compositions related to and based on these sequences, and methods of using these sequences and compositions.
    Type: Application
    Filed: July 22, 2003
    Publication date: June 22, 2006
    Inventors: Edward Yeh, Limin Gong
  • Patent number: 6596527
    Abstract: The invention relates to a novel protease, called SENP1, which is active against sentrin-modified proteins in vivo. The invention more specifically relates to the genomic and amino acid sequences for SENP1, compositions related to and based on these sequences, and methods of using these sequences and compositions.
    Type: Grant
    Filed: July 31, 2000
    Date of Patent: July 22, 2003
    Assignee: Board of Regents, The University of Texas Sytem
    Inventors: Edward T. H. Yeh, Limin Gong